Literature DB >> 9824165

The major SHP-1-binding, tyrosine-phosphorylated protein in macrophages is a member of the KIR/LIR family and an SHP-1 substrate.

K L Berg1, K Carlberg, L R Rohrschneider, K A Siminovitch, E R Stanley.   

Abstract

The SH2 domain-containing cytoplasmic protein tyrosine phosphatase, SHP-1, negatively regulates hematopoietic cell signaling. SHP-1 is associated with a tyrosine phosphorylated, plasma membrane-spanning glycoprotein, pp130, in colony stimulating factor-1 stimulated or unstimulated macrophages. This association is phosphotyrosine dependent and is mediated by the amino-terminal SH2 domain of SHP-1. pp130 behaves as a substrate of SHP-1 in vitro and is hyperphosphorylated on tyrosine in SHP-1 deficient macrophages from viable-motheaten mice. Co-immunoprecipitation data indicate that pp130 is the product of the mouse p91/PIR-B gene that encodes a member of the killer cell inhibitory receptor (KIR)/leukocyte immunoglobulin-like receptor (LIR) family. By analogy to the KIRs, p91/PIR-B may represent a novel class of macrophage receptors which act to suppress macrophage activation. These observations identify SHP-1 interactions with and regulation of p91/PIR-B as a potential mechanism for inhibiting the signaling cascades linking extracellular stimuli to macrophage activation and/or development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824165     DOI: 10.1038/sj.onc.1202203

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B.

Authors:  C C Chen; V Hurez; J S Brockenbrough; H Kubagawa; M D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

2.  ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice.

Authors:  J L Smith; A E Schaffner; J K Hofmeister; M Hartman; G Wei; D Forsthoefel; D A Hume; M C Ostrowski
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 3.  Shp1 function in myeloid cells.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  J Leukoc Biol       Date:  2017-06-12       Impact factor: 4.962

4.  Structure and flexibility of the extracellular region of the PirB receptor.

Authors:  Hedwich C Vlieg; Eric G Huizinga; Bert J C Janssen
Journal:  J Biol Chem       Date:  2019-01-23       Impact factor: 5.157

5.  Protein tyrosine phosphatase phi regulates paxillin tyrosine phosphorylation and mediates colony-stimulating factor 1-induced morphological changes in macrophages.

Authors:  F J Pixley; P S Lee; J S Condeelis; E R Stanley
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

6.  Regulation of urokinase plasminogen activator gene transcription in the RAW264 murine macrophage cell line by macrophage colony-stimulating factor (CSF-1) is dependent upon the level of cell-surface receptor.

Authors:  L F Fowles; K J Stacey; D Marks; J A Hamilton; D A Hume
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

Review 7.  Leishmania interferes with host cell signaling to devise a survival strategy.

Authors:  Suvercha Bhardwaj; Neetu Srivastava; Raki Sudan; Bhaskar Saha
Journal:  J Biomed Biotechnol       Date:  2010-04-08

8.  Evasion of Host Defence by Leishmania donovani: Subversion of Signaling Pathways.

Authors:  Md Shadab; Nahid Ali
Journal:  Mol Biol Int       Date:  2011-04-27

9.  Negative regulation of phagocytosis in murine macrophages by the Src kinase family member, Fgr.

Authors:  H D Gresham; B M Dale; J W Potter; P W Chang; C M Vines; C A Lowell; C F Lagenaur; C L Willman
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

10.  Abnormal chemokine-induced responses of immature and mature hematopoietic cells from motheaten mice implicate the protein tyrosine phosphatase SHP-1 in chemokine responses.

Authors:  C H Kim; C K Qu; G Hangoc; S Cooper; N Anzai; G S Feng; H E Broxmeyer
Journal:  J Exp Med       Date:  1999-09-06       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.